Literature DB >> 12886524

Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia.

Andreas P Berger1, Kurt Kofler, Jasmin Bektic, Hermann Rogatsch, Hannes Steiner, Georg Bartsch, Helmut Klocker.   

Abstract

BACKGROUND: Local hypoxia may be one of the triggers of embryonic reawakening of the stroma and subsequent hyperplastic growth in the prostate. Using a cell culture model of human prostatic stromal cells, we investigated the effects of hypoxia on activation of hypoxia-inducible factor 1 (HIF 1) and on the production of growth factors.
METHODS: Primary prostatic stromal cells were grown in normal and hypoxic (1% O(2)) atmosphere. Activation of HIF 1 was evaluated after different time intervals by Western blot. Induced secretion of growth factors VEGF, FGF-7, TGF-beta, IL 8, and FGF-2 were analyzed by ELISA. To confirm the in vitro findings we also performed immunohistochemistry of HIF 1alpha as well as pro-collagen I, collagens I, III, and IV in the benign tissue of radical prostatectomy specimens.
RESULTS: HIF 1 is activated in a time-dependent manner, already starting 1 hr after exposure of stromal cells to hypoxic conditions. Secretion of VEGF, FGF-7, TGF-beta, FGF-2, and IL 8 is increased under hypoxic in vitro conditions in comparison to normoxia. Levels of TGF-beta, VEGF, and IL 8 were rapidly and statistically significantly increased in the supernatant of hypoxic cells. Consistent with the in vitro findings, immunohistochemistry of HIF 1alpha in (benign prostatic hyperplasia) BPH tissue revealed strong HIF 1alpha nuclear staining in hyperplastic areas. No difference was observed in the collagen pattern between hyperplastic and normal prostate tissue.
CONCLUSIONS: Prostatic stromal cells respond to hypoxia by upregulation of secretion of several growth factors suggesting that hypoxia can trigger prostatic growth. Therefore, hypoxia might be a key factor contributing to the pathogenesis of BPH. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12886524     DOI: 10.1002/pros.10279

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  24 in total

1.  Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation.

Authors:  Philip P Fitchev; Susan M Wcislak; Chung Lee; Anders Bergh; Charles B Brendler; Veronica M Stellmach; Susan E Crawford; Constantine D Mavroudis; Mona L Cornwell; Jennifer A Doll
Journal:  Lab Invest       Date:  2010-05-10       Impact factor: 5.662

Review 2.  Benign prostatic hyperplasia: dietary and metabolic risk factors.

Authors:  H Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-02-02       Impact factor: 2.370

3.  Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells.

Authors:  Maura Calvani; Annamaria Rapisarda; Badarch Uranchimeg; Robert H Shoemaker; Giovanni Melillo
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

4.  Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer.

Authors:  Quynh-Thu Le; Richard Fisher; Kelly S Oliner; Richard J Young; Hongbin Cao; Christina Kong; Edward Graves; Rodney J Hicks; Grant A McArthur; Lester Peters; Brian O'Sullivan; Amato Giaccia; Danny Rischin
Journal:  Clin Cancer Res       Date:  2012-03-01       Impact factor: 12.531

5.  Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells.

Authors:  Caroline Muir; Leland W K Chung; Daniel D Carson; Mary C Farach-Carson
Journal:  Clin Exp Metastasis       Date:  2006-07-07       Impact factor: 5.150

Review 6.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

Review 7.  Predictive medicine in non-malignant urological disorders.

Authors:  Mariangela Mancini; Antonio Cisternino; Ivan Matteo Tavolini; Fabrizio Dal Moro; Pierfrancesco Bassi
Journal:  World J Urol       Date:  2003-12-20       Impact factor: 4.226

8.  Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.

Authors:  A P Berger; M Deibl; E J Halpern; M Lechleitner; J Bektic; W Horninger; G Fritsche; H Steiner; A Pelzer; G Bartsch; F Frauscher
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

9.  Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1α, and NF-κB.

Authors:  Reem T Atawia; Hala H Mosli; Mariane G Tadros; Amani E Khalifa; Hisham A Mosli; Ashraf B Abdel-Naim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-28       Impact factor: 3.000

Review 10.  Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting.

Authors:  Arich Ryan Reynolds; Natasha Kyprianou
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.